Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa F Long

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Annals of Internal Medicine|December 22, 2010
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United StatesElisa F Long, Margaret L Brandeau, Douglas K Owens
Journal of Neurosurgery|November 26, 2008
Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic strokeChirag G Patil, Elisa F Long, Maarten G Lansberg
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2020
Nursing home staff networks and COVID-19M Keith Chen, Judith A Chevalier, Elisa F Long
BMC Infectious Diseases|April 19, 2015
Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, GhanaAdam VanDeusen, Elijah Paintsil, Thomas Agyarko-Poku, et al.
Journal of Cancer Survivorship : Research and Practice|December 31, 2021
Current practice patterns and gaps in guideline-concordant breast cancer survivorship careEden R Brauer, Elisa F Long, Laura Petersen, et al.
Health Care Management Science|June 25, 2013
HIV epidemic control-a model for optimal allocation of prevention and treatment resourcesSabina S Alistar, Elisa F Long, Margaret L Brandeau, et al.
Plos One|February 7, 2015
Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United StatesDahye L Song, Frederick L Altice, Michael M Copenhaver, et al.
Journal of Oncology Practice|December 15, 2018
Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry ListEden R Brauer, Elisa F Long, Joy Melnikow, et al.
AIDS (London, England)|July 1, 2011
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USAJessie L Juusola, Margaret L Brandeau, Elisa F Long, et al.
Plos One|April 26, 2014
Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United KingdomElisa F Long, Roshni Mandalia, Sundhiya Mandalia, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Annals of Internal Medicine|December 22, 2010
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United StatesElisa F Long, Margaret L Brandeau, Douglas K Owens
Journal of Neurosurgery|November 26, 2008
Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic strokeChirag G Patil, Elisa F Long, Maarten G Lansberg
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2020
Nursing home staff networks and COVID-19M Keith Chen, Judith A Chevalier, Elisa F Long
BMC Infectious Diseases|April 19, 2015
Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, GhanaAdam VanDeusen, Elijah Paintsil, Thomas Agyarko-Poku, et al.
Journal of Cancer Survivorship : Research and Practice|December 31, 2021
Current practice patterns and gaps in guideline-concordant breast cancer survivorship careEden R Brauer, Elisa F Long, Laura Petersen, et al.
Health Care Management Science|June 25, 2013
HIV epidemic control-a model for optimal allocation of prevention and treatment resourcesSabina S Alistar, Elisa F Long, Margaret L Brandeau, et al.
Plos One|February 7, 2015
Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United StatesDahye L Song, Frederick L Altice, Michael M Copenhaver, et al.
Journal of Oncology Practice|December 15, 2018
Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry ListEden R Brauer, Elisa F Long, Joy Melnikow, et al.
AIDS (London, England)|July 1, 2011
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USAJessie L Juusola, Margaret L Brandeau, Elisa F Long, et al.
Plos One|April 26, 2014
Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United KingdomElisa F Long, Roshni Mandalia, Sundhiya Mandalia, et al.
Pageof 3